Neurizon Therapeutics (ASX:NUZ) Pre-Tax Income : A$-14.58 Mil (TTM As of Dec. 2024)

Neurizon Therapeutics Pre-Tax Income Chart

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial															-1.23	-0.02	-1.60	-7.30	-7.28

Competitive Comparison of Neurizon Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Neurizon Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Pre-Tax Income falls into.

Neurizon Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Neurizon Therapeutics's Pretax Income for the fiscal year that ended in Jun. 2005 is calculated as

Neurizon Therapeutics's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-14.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurizon Therapeutics  (ASX:NUZ) Pre-Tax Income Explanation

Neurizon Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

During the past 6 years, Neurizon Therapeutics's highest Pretax Margin was -104.05%. The lowest was -738.57%. And the median was -606.18%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurizon Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description